M1 Kliniken AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: DE000A0STSQ8
EUR
19.32
0.78 (4.21%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Company has a low Debt to Equity ratio (avg) at times

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 37.05%

 
3

With ROE of 17.52%, it has a Attractive valuation with a 2.66 Price to Book Value

4

Underperformed the market in the last 1 year

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 380 Million ()

stock-summary
P/E

15.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

2.59%

stock-summary
Debt Equity

-0.17

stock-summary
Return on Equity

17.52%

stock-summary
Price to Book

3.22

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
43.11%
0%
43.11%
6 Months
35.86%
0%
35.86%
1 Year
19.63%
0%
19.63%
2 Years
106.85%
0%
106.85%
3 Years
216.72%
0%
216.72%
4 Years
162.5%
0%
162.5%
5 Years
108.64%
0%
108.64%

M1 Kliniken AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
37.05%
EBIT Growth (5y)
46.20%
EBIT to Interest (avg)
10.03
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.07
Sales to Capital Employed (avg)
2.61
Tax Ratio
32.35%
Dividend Payout Ratio
57.92%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
16.23%
ROE (avg)
10.09%
Valuation key factors
Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
2.66
EV to EBIT
9.71
EV to EBITDA
8.29
EV to Capital Employed
3.01
EV to Sales
0.83
PEG Ratio
0.78
Dividend Yield
3.12%
ROCE (Latest)
31.00%
ROE (Latest)
17.52%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
Mildly Bullish
Mildly Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by M1 Kliniken AG"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 10.87% vs -9.31% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -100.00% vs -34.86% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "316.30",
          "val2": "285.30",
          "chgp": "10.87%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "15.70",
          "val2": "14.60",
          "chgp": "7.53%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.80",
          "val2": "0.80",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.70",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.00",
          "val2": "7.10",
          "chgp": "-100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "49.60%",
          "val2": "30.50%",
          "chgp": "1.91%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
316.30
285.30
10.87%
Operating Profit (PBDIT) excl Other Income
15.70
14.60
7.53%
Interest
0.80
0.80
Exceptional Items
0.00
0.70
-100.00%
Consolidate Net Profit
0.00
7.10
-100.00%
Operating Profit Margin (Excl OI)
49.60%
30.50%
1.91%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 10.87% vs -9.31% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -100.00% vs -34.86% in Dec 2022

stock-summaryCompany CV
About M1 Kliniken AG stock-summary
stock-summary
M1 Kliniken AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available